NCT01210885 - Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents | Biotech Hunter

Enrollment

495

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Meningococcal DiseaseMeningococcal Meningitis

Interventions

BIOLOGICAL

Meningococcal Vaccine

MenABCWY combination vaccine containing four different rMenB formulations with MenACWY, intramuscular (IM) administration, vaccination at 0 and 2 months.

Trial Locations (8)

Unknown

CESFAM Gabriela Mistral, Santiago

Liceo Carmela Carvajal de Prat, Santiago

Pontificia Universidad Católica de Chile, Santiago

CafeSalud M P (Dir. de Investigación y Proyectos Especiales), Bogotá

Centro de Atencion e Investigacion Medica - CAIMED, Bogotá

Centro de Investigaciones CAFAM, Bogotá

Health Research International, Panama City

Indicasat, Panama City